市場調查報告書

使用幹細胞的軟骨再生的全球市場 - 市場規模,佔有率,預測,市場機會分析 2018年∼2026年

Stem Cell Cartilage Regeneration Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

出版商 Coherent Market Insights 商品編碼 785799
出版日期 內容資訊 英文 154 Pages
商品交期: 2-3個工作天內
價格
Back to Top
使用幹細胞的軟骨再生的全球市場 - 市場規模,佔有率,預測,市場機會分析 2018年∼2026年 Stem Cell Cartilage Regeneration Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
出版日期: 2019年01月24日內容資訊: 英文 154 Pages
簡介

骨關節炎的罹患數全世界的增加,成為使用幹細胞的軟骨再生市場主要成長要素。還有政府機關提高幹細胞治療引進的政策也預計促進不久將來這個市場成長。可是,使用幹細胞的軟骨再生治療成本高,成為抑制市場成長的要素。

本報告提供全球使用幹細胞的軟骨再生市場調查,市場概要,各幹細胞類型、治療、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各幹細胞類型
    • 市場片段:各治療
    • 市場片段:各終端用戶
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 法規狀況
  • PEST分析

第4章 使用幹細胞的軟骨再生市場:各幹細胞類型

  • 簡介
  • 造血幹細胞(HSC)
  • 多功能幹細胞(iPSC / ESC)
  • 間質幹細胞(MSC)

第5章 使用幹細胞的軟骨再生市場:各治療

  • 簡介
  • 微骨折
  • 軟骨移植
  • 自體軟骨細胞移植術
  • 幹細胞注射

第6章 使用幹細胞的軟骨再生市場:各終端用戶

  • 簡介
  • 醫院、診療所
  • 門診外科中心

第7章 使用幹細胞的軟骨再生市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭環境

  • 企業簡介
    • Theracell Advanced Biotechnology Ltd.
    • Orthocell Ltd.
    • Xintela AB
    • CellGenix GmbH
    • Merck KGaA
    • Osiris Therapeutics, Inc.
    • BioTissue SA
    • Vericel Corporation

第9章 Section

  • 分析師的意見
  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making it an ideal choice for use as seed cells. Growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration.

Market Dynamics

Growing osteoarthritis incidence among the global population is supporting the adoption of stem cell cartilage regeneration therapy. For instance, according to November 2017, Arthritis Foundation data findings, with the increase in global geriatric population, degenerative disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050.

Furthermore, various government agencies are focusing on policies to enhance adoption of stem cell therapies, which is expected to drive growth of stem cell cartilage regeneration market in the near future. For instance, in December 2016, the 21st Century Cures Act (Cures Act) was signed into law by the U.S. FDA, thereby allowing legislation for an expedited approval path for cellular medicines designated as regenerative medicine advanced therapies (RMATs) to patients who are in need of it.

However, high cost of treatment is expected to hamper the stem cell cartilage regeneration market during the forecast period. Moreover, extensive time and expertise required to perform stem cell based therapy leads to increase the cost of this procedure. In some cases, the physician must pay licensing fees to access stem cell sourcing, processing, or delivering these technologies.

Key features of the study:

  • This report provides in-depth analysis of the stem cell cartilage regeneration market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global stem cell cartilage regeneration market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global stem cell cartilage regeneration market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for stem cell cartilage regeneration market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
  • Global Stem Cell Cartilage Regeneration Market, By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
  • Global Stem Cell Cartilage Regeneration Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
  • Global Stem Cell Cartilage Regeneration Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
      • By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
      • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
  • Company Profiles
    • Theracell Advanced Biotechnology Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Orthocell Ltd.
    • Xintela AB
    • CellGenix GmbH
    • Merck KGaA
    • Osiris Therapeutics, Inc.
    • BioTissue SA
    • Vericel Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Stem Cell Type
    • Market Snippet, By Treatment
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Landscape
  • PEST Analysis

4. Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hematopoietic Stem Cells (HSCs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Pluripotent Stem Cells (iPSC/ESCs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Mesenchymal Stem Cells (MSCs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Stem Cell Cartilage Regeneration Market, By Treatment, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Microfracture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Osteochondral Transplant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Autologous Chondrocyte Implantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Stem Cell Injections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Stem Cell Cartilage Regeneration Market, By End User, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Stem Cell Cartilage Regeneration Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Stem Cell Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Theracell Advanced Biotechnology Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Orthocell Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Xintela AB
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CellGenix GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Osiris Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioTissue SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Vericel Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

9. Section

  • Analyst Views
  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top